Pipelines in Oncology: Abbott Oncology
PIPELINES IN ONCOLOGY - ABBOTT ONCOLOGY
A series of product development presentations sponsored by DF/HCC
Saul Rosenberg, PhD Senior Director Discovery
Gary Gordon MD, PhD: Divisional Vice President Pharmaceutical Development
TOPICS/PRODUCTS TO BE PRESENTED:
ABT-869, a small molecule receptor tyrosine kinase inhibitor of VEGF&PDGF
ABT-263, a small molecule inhibitor of BCL-2 family of proteins
ABT-888, a small molecule inhibitor of PARP (poly ADP-ribose polymerase)
March 20, 2008, 4:00 - 6:00 PM
Dana-Farber Cancer Institute, Dana 1620
Video Conference to MGH Lawrence House 2nd floor conference room
These presentations are not for the public and designated for members of the DF/HCC institutions only.
PARKING: Please park in DFCI's Smith Garage at One Jimmy Fund Way.
DFCI will validate parking for the event.